Author Information
Rubén Pío is a prominent researcher affiliated with the University of Navarra, where he is part of the Center for Applied Medical Research (CIMA), focusing on the Program in Solid Tumors and Biomarkers. He is also associated with Navarra's Health Research Institute (IdiSNA) and the Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) in Spain. Additionally, he serves in the Department of Biochemistry and Genetics at the University of Navarra's School of Sciences in Pamplona, Spain.Research Contributions
Rubén Pío has made significant contributions to the field of cancer research, particularly focusing on tumor biology and immunotherapy. His work has explored the role of myeloid-derived suppressor cells in cancer, the molecular biomarkers in early-stage lung cancer, and the therapeutic efficacy of oncolytic virus and complement inhibitors in DIPG models. He has also investigated the impacts of therapies such as Dasatinib in combination with Anti-PD-1 in NSCLC models, highlighting his diverse involvement in cutting-edge cancer research.Aliases
Throughout his academic career, Rubén Pío has published under various aliases, including Rubén Pı́o, R Pı́o, R. Pío, Ruben Pio, Rubén Pío, R Pio, Rubén Pı́o, R Pío, R. Pio, and Ruben Pío.Publication and Citation Metrics
| Metric |
Value |
| Total Citations |
6,327 |
| H-index |
45 |
| Total Papers |
186 |
